chrisvoncsefalvay/vaers-outcomes huggingface dataset:
tinnitus; Head numbness /facial/head numbness; pain; lymphnode hardening / swollen lymph nodes; This is a spontaneous report from a contactable consumer (patient).  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), on 16Mar2021 at 11:00 (first dose , lot ER9810 ) and  on 06Apr2021 at 11:15 (second dose, lot ER8732), both intramuscular in left shoulder at single doses for covid-19 immunisation .  Patient medical history and concomitant medications were none. Family medical history included ascending crucial aneurysm- congenital , intermittent high blood pressure  especially when doctors, lawyers  or cops and COPD from smoking but quit 3 years ago (relatives were not specified).The patient experienced tinnitus and head numbness on 16Mar2021 at 15:00, both serious per disability; on an unknown date in 2021 pain and lymphnode hardening occurred. The events were described as follows: first dose side effects were awful. Tinnitus, facial/head numbness and swollen lymph nodes-painful. The outcome of the events was not reported. Patient will want to see Anti-Histamines might help  and didn't want to take them with shots  they may get side agitated (as) reported.No treatment given.Similar events were reported after second dose, however condition was less awful compare to first dose. Tinnitus was less acute in tone and volume, numbness only on right top back of head (on an unknown date in 2021). Lymph gland on left side tender on 06Apr2021 at 13:00  and painful. Outcome of the events was recovering. It was reported that doctor looked in but couldn't see inner ear. It was suggested to go to ENT; patient lost insurance  took the chance on 2nd dose because doctor  would and could not say if the 2nd would be a repeat of 1st (as rpeorted). Patient figured he/she'd just lose the mind to the sound and numbness since so much doctor could not say 2nd would be repeat of first (as reported).No follow-up attempts are needed. No further information is expected.
I waited at the clinic for 30 minutes, but when I left I realized that I was a bit dizzy, itchy (without hives), and flushed.  I took 50mg of Benadryl and waited in my car until I felt safe to drive again (about ten minutes).    By evening, I felt like I had been punched in the left bicep.  I also had some minor flu-like symptoms (muscle and join pain) that resolved with Tylenol.  Today is two days after receiving the vaccine and I feel perfectly fine.
Slight headache and body aches, fatigue.  Over the course of about 2-3 days, beginning at about day 6 after 2nd dose of vaccine.
This solicited report was received from a pharmacist who is also the patient's father, concerning his 16-year-old daughter. The patient was enrolled in a Market Research program . The patient did not have any concurrent conditions, medical history or concomitant therapies. On an unknown date, the subject was vaccinated with GARDASIL, injection (dose, route and anatomical site of injection were not reported). On an unknown date the subject experienced pain when she received the injection of GARDASIL, injection., It was reported that the information regarding the vaccination's responsible physician was unknown. Also, there were no diagnostic test performed. At the time of reporting, the outcome of injection site pain was reported as recovered on an unknown date. The investigator considered injection site pain to be related to GARDASIL. Additional information is not expected as the reporter refused additional contact.
Headache, fatigue progression of symptoms to severe fatigue, throat discomfort, low grade fever, oral sores, croup like coughing. Diagnosed with Guillane Barre and active mono.
Exactly 24 hours after I received the first COVID shot (4/3), I got a sudden a migraine headache that lasted approximately 8 hours , then subsided. I have never had a migraine before in my life  I felt OK 2 days after receiving the shot, however, on the 3rd day (4/5), I developed intense jaw pain and locking with muscle stiffness and headaches. For almost a week, I could not close my mouth all the way to chew. Once I was able to close my mouth again, it was painful to open it all the way for an additional week. All told, I had the headache and jaw pain/locking for 2 weeks total.  I was seen by a specialist but because the pain went away as mysteriously as it came, I am not currently under any medical care for this condition. It's notable that I had zero side effects from the second shot, which I got on 5/4. One thing I have noticed is that my jaw is tighter than it was before (but no lingering pain). I notice that I am grinding my teeth and that is not an issue I had prior to receiving the vaccine.
After the shot it became bruised in the area for 3 days. Soon after coming home there became itchy spots, after two more days my legs were also itchy. Only after 10 days did these symptoms go away
All side effect experienced and severe. Extreme headache starting 12 hours after injection, fever, chill, sore body, sore arm. Heartbeat start racing once fever started and sustain at 145 beat per minute for over a day, and over 110 over the next day. Heartbeat has not returned to normal after 3 days. Other reactions subsided after 60 hours, with lightheadedness still lingers after 60 hours.
mom states pt devel a rash & sz activity 5 days p/shots;pt had low fever x 3 days then 11FEB96 pt devel rash & sz activity;mom called MD that evening & did not f/u w/visit;dx tremor;
c/o sudden onset f arm pain @ inj site;warm to touch, achey, pain across shoulder blade 25APR97;
Got covid-19 11 days after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Got covid-19 11 days after 1st dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Got covid-19 11 days after 1st dose). At the time of the report, COVID-19 (Got covid-19 11 days after 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment medications were provided.   This case was linked to MOD-2021-311244 (Patient Link).
Shortness of breath; Heart palpitations; Legs are weak; Dizziness; This spontaneous case was reported by a patient family member or friend and describes the occurrence of DYSPNOEA (Shortness of breath) and PALPITATIONS (Heart palpitations) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNK) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Urinary tract infection (hospitalized with urinary tract infection) in 2020.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Shortness of breath) (seriousness criterion hospitalization), PALPITATIONS (Heart palpitations) (seriousness criterion hospitalization), MUSCULAR WEAKNESS (Legs are weak) and DIZZINESS (Dizziness). At the time of the report, DYSPNOEA (Shortness of breath), PALPITATIONS (Heart palpitations), MUSCULAR WEAKNESS (Legs are weak) and DIZZINESS (Dizziness) outcome was unknown.            No concomitant medication information was reported. No treatment information was reported.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.       Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 25-Jun-2021: Additional events.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Patient with fever starting 6 hours vaccines and then at 4:00 with febrile seizure less than 5 min and fever documented in ED to 104. Fever gone after 36 hours. Normal exam with no other symptoms.
Local induration, swelling, heat, redness 4 cm x 8 cm.
74 yr old who exhibited pain during and since covid vaccine administration without prior injury or Hx of pain in affected shoulder
I got swollen lymph nodes on my shoulder and collar bone on April 18, 2021, 6 days after my Covid-19 vaccine (second dose). I went to the doctor, and they did blood work. I also got an ultrasound done. I still have a couple of the lymph nodes on my collar bone. They're much smaller now, but I will be going back to the doctor to get them looked at again.
This spontaneous case, initially received on 17-Oct-2016, was reported by a company representative and concerns an 18-year-old female patient. Weight: not provided; Height: not provided. Administration of company suspect drug(s): On an unknown date (after NEXPLANON insertion), the patient received Influenza Virus Vaccine (INN) for indication not reported. Dose regimen: Not reported, Route of administration: Not reported. Batch number: Not reported. Non-company suspect drugs: On 07-Sep-2016, the patient received NEXPLANON for the prevention of pregnancy. Dose regimen: Not reported, Route of administration: Intradermal. Batch number: Not reported. Adverse reactions/events and outcomes: On an unspecified date in 2016 following NEXPLANON insertion and subsequent flu vaccination, the patient was diagnosed with shingles in her retina (did not specify which eye) (medically significant, outcome: recovering / resolving). The reporter stated that the patient was already symptomatic during the time of the flu shot with spots on her face and forehead. The patient sought medical attention (office visit). It is unknown whether the patient received treatment or whether lab diagnostic studies were performed. Sender's Comments: Company comments: Listedness: Brand of vaccine not specified. Assessment according to the CCDS for CSL's Inactivated Influenza Virus Vaccine, Herpes ophthalmic is unlisted. Causality: Not Related. Patient was symptomatic with lesion on her face at time of receiving vaccination. Ophthalmic herpes zoster is due to varicella-zoster virus  reactivation involving in the ophthalmic division of the trigeminal nerve; hence not related to Influenza vaccine.
Area around injection is large, red, and swollen, hot to the touch. Arm is also very sore.
Initial and follow up information has been received from a physician concerning an 82 year old retired male who on 08-JUN-2007 15:00 was vaccinated in the right deltoid with a first dose of Zostavax (Oka/Merck) (Lot#657765/0585U). On 10-JUN-2007, at 10:00 the patient developed a rash which was diagnosed as herpes zoster. There was no other illness at the time of vaccination. There were groups of erupted vesicles and rash on T2 of the trigeminal nerve only on the right side. The patient had a blood pressure of 142/60 and temperature of 100.9 in the doctors office on 14-JUN-2007. The physician prescribed VICODIN, ZOVIRAX and LYRICA. As of 25-JUN-2007 the patient had recovered. There was no product quality complaint. Additional information is not expected.
BlurredVision, Headache, lightheadedness, visual disturbance, diaphoresis Narrative:  has orthostatic hypotension - referred to emergency room
I was not able to sleep that night for I started having muscle pain, The muscle pain became do bad i was close to tears. Beyond muscle pain I also had joint pain an a headache. Also fatigue and lost of appetite. I continually took Tylenol, Advil and Robitusen Cold and Flu. I am on day 2, still have not eaten. The muscle pain is starting to ease up but not very exhausted.
I've experienced headaches that last 2-3 days on and off the last several months since taking the vaccine.; I also feel arm soreness once in awhile at the site the injections were made.; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 50-year-old male patient received bnt162b2 (BNT162B2), administered in left arm, administration date 08May2021 (Lot number: EW0179) at the age of 50 years as dose 2, single for COVID-19 immunisation. Relevant medical history included: "None" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot number: EW0170, Anatomical site: left arm), administration date: 17Apr2021, when the patient was 50 years old, for COVID-19 immunisation, reaction: "Vaccination site pain".   The following information was reported: HEADACHE (non-serious) with onset 08May2021, outcome "not recovered", described as "I've experienced headaches that last 2-3 days on and off the last several months since taking the vaccine"; VACCINATION SITE PAIN (non-serious) with onset 08May2021, outcome "not recovered", described as "I also feel arm soreness once in awhile at the site the injections were made". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of headache and vaccination site pain.  Additional information: The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The headaches were new, the patient did not have them prior to taking the vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care.Have not had any blood tests. Only know that have had headache almost weekly since getting vaccine. Otc pill, Advil, Tylenol, and aspirin does not help them. They last a day or two which is unsuccessful.   Follow-Up (14Dec2021):Follow-up attempts are completed. No further information is expected.  Follow-up (14Feb2022): This is a follow-up spontaneous report from a contactable consumer. This consumer reported in response to Non-HCP letter sent which included that: Narrative updated.   Follow-up attempts are completed and no further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101756922 similar report from same reporter
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55-year-old male patient received BNT162b2 (BNT162B2), on 18Mar2021 as dose 1, single (Lot number: EP7534), in left arm, on 08Apr2021 as dose 2, single (Lot number: EW0150), in left arm, on 17Nov2021 as dose 3 (booster), single (Lot number: FJ1611), in left arm and on 18Apr2022 as dose 4 (booster), single (Lot number: FJ4989) at the age of 55 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Past drug history included: Doxycycline, reaction(s): "Allergy:Doxycycline", notes: Known allergies: Doxycycline. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: Patient took Anti-viral product Paxlovid indicated for COVID 19, and treatment started on 14Jul2022, Treatment stopped on 19Jul2022. Patient was not taking any other medications/products within 2 weeks of starting COVID-19 treatment. Patient previously received a COVID-19 Vaccine. It was reported that patient had a rebound case of covid, and the symptoms were far more severe than his initial case. Adverse events start date was reported as17Jul2022. Patient was Recovering. No treatment ae was reported. In other medical history was reported as None. Possible undiagnosed autoimmune disease. Device Date was reported as 30Jul2022.
1/3/00, pt developed generalized hives/itchiness, took benadryl. 1/4/00 6:30 a.m. hives worsened, face swollen.  6:30 pm, fever began and respiratory difficulty.  Went to ER. Rcvd O2 and observed for 4 hours.
I was experiencing what I understand to be one of the more common side effects: pain at injection site. This pain kind of traveled to other parts of my arm and eventually my arm pit. I noticed the pain travelling around the date of 1/2/2021, and by 1/6/2021 it getting more intense. As I was trying to massage out the soreness, I noticed a palpable, painful lump in my right breast. I did not immediately recognize it as a swollen lymph node at that time, but after several Dr exams, and the lump and pain decreasing, I believe that is what was happening. I do still have the lump, and it is tender, so I am currently monitoring it.
1st dose of Shingrix on 08Jan2020 and is late for the 2nd dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 59-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 08th January 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided are as follows: The age at vaccination was not applicable for this report. The pharmacist reported that the patient was late for the 2nd dose of Shingrix, which led to incomplete course of vaccination. No further information reported.
Pt had c/o nausea, H/A, fever and rash on right side of face.  Rash is papular of 0.5mm.  Max temp was at home of 101.3F.   Pt given Benadryl, 25mg, prednisone 40mg, lortab 5mg, and reglan 10mg IV.
Roughly about two hours after receiving the first vaccine, my arm started to get sore. At around 9 p.m. I developed chills but no fever. I kept getting random episodes of chills after that. When I went to bed at 10:45 p.m., I had another episode of the chills. I took one teaspoon(half a recommended dose) of Nyquil to help me sleep. I woke up suddenly again with chills and I had a temperature of 100 degrees. I took another teaspoon of Nyquil to help bring down my fever and that helped.
Pt showed me a 2 inch long area of redness that is warm to the touch, also one injection site has a small nodule you can feel under the skin. Pt got the immunizations on 4/19/22 and presented to the pharmacy on 04/22/23 complaining of the adverse reaction.
felt excessively tired the next morning for about 1/2 the day; 12 hours after injection he had extreme cold chills for about 2 hours; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54 year-old male patient received bnt162b2 (BNT162B2), administration date 30Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose 1, single), for covid-19 immunisation. The following information was reported: CHILLS (non-serious) with onset Mar2021, outcome "recovered" (Mar2021), described as "12 hours after injection he had extreme cold chills for about 2 hours"; FATIGUE (non-serious) with onset 31Mar2021, outcome "recovered" (31Mar2021), described as "felt excessively tired the next morning for about 1/2 the day". Felt fine after midday.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt. fully vaccinated with Pfizer: dose 1 on 1/19/21 dose 2 on 2/9/21.  Pt. had a high risk community exposure to a COVID+ household member prior to Pt. symptom onset on 8/28/21. Symptoms include runny nose, body aches, cough, sore throat, fever, chills, headache, loss of taste, loss of smell. EE tested COVID positive 9/4/21 at ED.
2/8/22 pt brought to hosp from nursing home (name of facility unknown) due to an altered mental state, pt has a blank stare today with son; pt had a positive COVID test on 1/13/22 and has been in isolation at nursing home until today; COVID test still positive on admission; admitted with acute encephalopathy, UTI secondary to Klebsiella pneumonia; treated with ABX; A fib with RVR; pt's condition declined; poor appetite; developed AKI and hypernatremia due to dehydration; DNR with limited therapy; NG tube inserted; pt expired in hospital after NG tube insertion
Pt mentioned to the vaccinator that she had developed hives after her first shot that she received on 3/2/2021.   She complained of itchiness and hives and had to take benadryl for 2 days until they were gone.  PT stayed at recovery area for 30 minutes to monitor for any anaphylactic response.  She left without further issues.  Contact information given to Pt in case anything develops later today.
I have suffered from mental confusion, headaches, fever and chills. My arm was also, that is all that I can remember.
Information has been received from a medical assistant referring to a 12 month old patient of unknown gender. Information about medical history, concurrent condition and concomitant medication was unknown. On 09-NOV-2018 the patient received an improperly stored dose of VARIVAX (lot # R012417, expiry date: 28-OCT-2019; dose, frequency and route were not reported) for prophylaxis, which was reconstituted with properly stored sterile diluent. No adverse effects were reported. There was no previous temperature excursion. It was also reported that temperature was from 15 Fahrenheit to 46 Fahrenheit for 8 hours and the data logger was involved. Sender's Comments: US-009507513-1902USA007542: US-009507513-1902USA007540: US-009507513-1902USA007543: US-009507513-1902USA007546: US-009507513-1902USA007547: US-009507513-1902USA007545: US-009507513-1902USA007539: US-009507513-1902USA007538: US-009507513-1902USA007536: US-009507513-1902USA007541: US-009507513-1902USA007537: US-009507513-1902USA007544: US-009507513-1902USA007549: US-009507513-1902USA007550: US-009507513-1901USA008772.
Chills; Severe migraine; fatigue; body aches; Joint pain; Slight nausea; Loss of appetite; Injection site pain; Swollen and painful lymph node under armpit of injection arm (right armpit); Swollen and painful lymph node under armpit of injection arm (right armpit); This is a spontaneous report from a contactable consumer (patient). A 36-years-old female non-pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EN6205, Expiration date: not reported), via an unspecified route of administration in arm left on 04Mar2021 at 11:30 AM (at the age of 36-years-old) as a dose 1, single for COVID-19 immunization. The patient's medical history included asthma, idiopathic intracranial hypertension, anxiety, depression, eczema and known allergies figs. The patient's concomitant medications in two weeks included fluticasone propionate, salmeterol xinafoate (ADVAIR) 250, magnesium, iron, isosorbide mononitrate (FLO), colecalciferol (D), probiotics, all were taken for an unspecified indication. It was reported that, the patient was not pregnant at time of vaccination. Other vaccine in four weeks was reported as no. Covid prior vaccination was reported as unknown and Covid tested post vaccination was reported as no. On 04Mar2021 at 18:00, the patient experienced chills, severe migraine, fatigue, body aches, joint pain, slight nausea, loss of appetite, injection site pain, swollen and painful lymph node under armpit of injection arm (right armpit). Treatment was not received for the events. The outcome of the events was not recovered.  No follow-up attempts are possible, information about lot/batch number cannot been obtained.